Â

Enphase Energy and Infinity Energy Expand Solar and Battery Deployments Across the United States

Retrieved on: 
Thursday, October 27, 2022
Lithium, LFP, SEC, LinkedIn, NASDAQ, Chemistry, Safety, CEO, Lithium iron phosphate, Adoption, Sunlight, Annual report, Technology, Maintenance, CA, GLOBE, Name, Weather, Twitter, Energy, ENPH, Â, IQ, Battery, Renewable energy, Electric battery, Enphase Energy, Facebook

FREMONT, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, announced today that Infinity Energy , a leading California-based solar and battery installer, is expanding the adoption of Enphase Energy Systems powered by IQ8 Microinverters and IQ Batteries, as the demand for energy security grows nationwide.

Key Points: 
  • FREMONT, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, announced today that Infinity Energy , a leading California-based solar and battery installer, is expanding the adoption of Enphase Energy Systems powered by IQ8 Microinverters and IQ Batteries, as the demand for energy security grows nationwide.
  • Infinity Energy currently serves customers in states including California, Colorado, Texas, and Florida, where there is high homeowner demand for residential solar energy solutions.
  • Our customers are experiencing rising energy costs and increasingly common extreme weather events leading to power outages said Bryson Solomon, CEO at Infinity Energy.
  • For homeowners who want battery backup , there are no sizing restrictions on pairing Enphase IQ Batteries with IQ8 Microinverters.

Clean Earth Ranks on Engineering News-Record 2022 Top 600 Specialty Contractors List

Retrieved on: 
Thursday, October 27, 2022
Harsco, Waste management, Company, Hazardous waste, LinkedIn, Russell, HSC, Contract, Â, Industry, News, GLOBE, Instagram, Name, Engineering, ENR, Recycling, Twitter, Construction, NYSE, Solution

Clean Earth appears on Engineering News-Records annual Top 600 Specialty Contractors list for 12th consecutive year.

Key Points: 
  • Clean Earth appears on Engineering News-Records annual Top 600 Specialty Contractors list for 12th consecutive year.
  • KING OF PRUSSIA, Pa., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Clean Earth , a division of Harsco Corporation and a leading provider in environmental and regulated waste management services, announced today that it has ranked on Engineering News-Records (ENR) annual Top 600 Specialty Contractors list.
  • The list ranks specialty contractors across the U.S. by year-end construction-specific revenue and categorizes the companies by the type of construction services provided.
  • Click here for the full list of names and ranks of ENRs 2022 Top 600 Specialty Contractors.

Escalade Reports Third Quarter and Year to Date 2022 Results

Retrieved on: 
Thursday, October 27, 2022
EBITDA, Company, Â, Acquisition, NASDAQ, Depreciation, Growth, CEO, Environment, Brunswick, ESCA, GLOBE, Review, Weather, Calendar, Tax, List, Investor relations, Life insurance, Holding company, Online gambling, Retail, Bank, Renewable energy, Escalade

EVANSVILLE, Ind., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Escalade, Inc. (NASDAQ: ESCA, or the Company), a leading manufacturer and distributor of sporting goods and indoor/outdoor recreational equipment, today announced third quarter and year to date results for 2022.

Key Points: 
  • EVANSVILLE, Ind., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Escalade, Inc. (NASDAQ: ESCA, or the Company), a leading manufacturer and distributor of sporting goods and indoor/outdoor recreational equipment, today announced third quarter and year to date results for 2022.
  • At the end of the third quarter 2022, net debt (total debt less cash) was 3.0x trailing twelve-month EBITDA.
  • Escalade announced a quarterly dividend of $0.15 per share to be paid to all shareholders of record on December 5, 2022 and disbursed on December 12, 2022.
  • The fourth quarter 2022 will end on December 31, 2022, then the Company will transition to its new financial reporting calendar for 2023.

Software Effective Solutions Subsidiary MEDCANA (OTC: SFJW) Announces Successful Launch of Test Greenhouses for Microclimates and Genetics with Colombia Partner Firms

Retrieved on: 
Thursday, October 27, 2022
Company, Economics, Â, SFWJ, Acquisition, Forward-looking statement, Laboratory, Hospital, Terminology, Industry, OTC, GLOBE, Soil, Humidity, Genetics, Cannabis, Wind, Drug, Oil

New Orleans, Louisiana, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Software Effective Solutions Corporation (OTC: SFWJ) (The Company, SFWJ) subsidiary Medcana is pleased to announce the successful launch of test greenhouses for microclimates and genetics with five partner firms in Colombia, South America.

Key Points: 
  • New Orleans, Louisiana, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Software Effective Solutions Corporation (OTC: SFWJ) (The Company, SFWJ) subsidiary Medcana is pleased to announce the successful launch of test greenhouses for microclimates and genetics with five partner firms in Colombia, South America.
  • The goal is to test microclimate, genetics, local pests, and any other factors that may affect the final design and selection of genetics.
  • As well, the greenhouses are a very small fraction of the planned builds but allow us to test conditions and begin micro-testing genetics.
  • For now, the greenhouses give Medcana and partners a controlled environment to ensure native soil results are accurate.

Nogin Unveils Vx Of Intelligent Commerce, The Leading Commerce-as-a-Service Software Platform

Retrieved on: 
Thursday, October 27, 2022
Commerce, Machine learning, LinkedIn, Running, NASDAQ, D2C, Growth, Â, CDP, GMV, Customer, DTC, Technology, Bronchopulmonary segment, Behavior, Algorithm, CAAS, GLOBE, Twitter, Investment, Time, Online shopping, Retail, Viktor Nogin

With these new capabilities, leading direct to consumer (D2C) ecommerce brands will now have the ability to elevate customer experiences and maximize potential profits.

Key Points: 
  • With these new capabilities, leading direct to consumer (D2C) ecommerce brands will now have the ability to elevate customer experiences and maximize potential profits.
  • The Nogin Commerce Platform contains the latest ecommerce technology innovation, delivering enterprise-scale results to smaller, growing brands.
  • Nogin (Nasdaq: NOGN, NOGNW), the Intelligent Commerce company, provides the worlds leading Commerce-as-a-Service (CaaS) technology platform for brand leaders that need to deliver superior growth with predictable costs and an exceptional online experience.
  • The Nogin Commerce Platform is a cloud-based ecommerce environment purpose-built for brands selling direct-to-consumer (D2C) and through online channel partners.

Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty

Retrieved on: 
Thursday, October 27, 2022
IDH1, MDS, Patent, Security (finance), U.S. Securities and Exchange Commission, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, NASDAQ, Goal, Cholangiocarcinoma, Food, Anemia, Lymphatic system, Agios Pharmaceuticals, Acute myeloid leukemia, Pyruvate kinase deficiency, Patient, Private Securities Litigation Reform Act, Culture, Partner, Ecosystem, Wilmer Cutler Pickering Hale and Dorr, Sickle cell disease, Leadership, Adult, GLOBE, COVID-19, Â, Tablet, Mutation, Marketing, FDA, Thalassemia, PK, Genetics, AML, Sale, PC, EMA, Pharmaceutical industry, Laboratoires Servier

In 2021, Agios completed the sale of its oncology portfolio including TIBSOVO to Servier.

Key Points: 
  • In 2021, Agios completed the sale of its oncology portfolio including TIBSOVO to Servier.
  • Agios retains its rights to a potential future milestone payment of $200 million for vorasidenib, as well as 15% royalties on U.S. net sales of vorasidenib.
  • As the result of a competitive process, we achieved an attractive valuation for the TIBSOVO royalty and identified an agile and collaborative financial partner in Sagard Healthcare Partners.
  • Agios is a pioneer in cellular metabolism with a track record of developing innovative, targeted therapies for patients with tremendous unmet need, said David MacNaughtan, Partner & Head of Sagard Healthcare Partners.

Fun Announces $3.9M in Pre-Seed Funding to Build dWallet Applications on Odsy Network

Retrieved on: 
Thursday, October 27, 2022
Crypto, Digital Currency Group, Machine learning, Blockchain, DAPP, CEO, Decentralized finance, MPC, Technology, Founder, Partnership, Nature, Algorithm, GLOBE, ConsenSys, Twitter, API, Marriage, Daos, Â, EdDSA, Entrepreneurship, Meta, CTO, VC, EOA, Solution, Cryptocurrency, Fun, Tinder

In this sense, Fun aims to serve as a ConsenSys-like product studio that leverages the dWallet primitive, powered by the Odsy Network, to develop more dynamic, secure, and expressive wallets and access control applications.

Key Points: 
  • In this sense, Fun aims to serve as a ConsenSys-like product studio that leverages the dWallet primitive, powered by the Odsy Network, to develop more dynamic, secure, and expressive wallets and access control applications.
  • Fun is the second VC-backed company dedicated to building applications on the Odsy Network, alongside dWallet Labs , a cybersecurity and blockchain company that recently raised $5M in a pre-seed funding round led by Digital Currency Group and Node Capital.
  • Fine continued, It's become increasingly clear that Odsy Network offers the most compelling infrastructure upon which to solve the wallet usability problem.
  • Were excited to leverage Odsy Network's new dWallet primitive to build game-changing wallet and access control solutions.

Arvinas Announces Winner of the 2022 Arvinas Early Career Researcher Award

Retrieved on: 
Thursday, October 27, 2022
Man, TPD, University, ARVN, Map, Reagan (2022 film), Humble & Fred, Breast cancer, Patient, Leadership, Research, GLOBE, Attention, Stem cell, Proteome, Â, Publius Cornelius Arvina, HAVEN

NEW HAVEN, Conn., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation (TPD), announced Katherine Donovan, Ph.D. of the Dana-Farber Cancer Institute/Harvard Medical School as the winner of the 2022 Arvinas Early Career Research Award last night at the 5 th Annual Targeted Protein Degradation Summit in Boston.

Key Points: 
  • NEW HAVEN, Conn., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation (TPD), announced Katherine Donovan, Ph.D. of the Dana-Farber Cancer Institute/Harvard Medical School as the winner of the 2022 Arvinas Early Career Research Award last night at the 5 th Annual Targeted Protein Degradation Summit in Boston.
  • Dr. Donovan received a monetary award of $25,000 to honor her leadership, innovation, and key scientific contributions to the field of TPD.
  • Arvinas is committed to supporting the work of researchers advancing the field of TPD around the world, and were thrilled to recognize Dr. Donovan and her contributions as our Arvinas Early Career Research Award winner, said John Houston, Ph.D., President and Chief Executive Officer at Arvinas.
  • I am both humbled and honored to be the recipient of the Arvinas Early Career Researcher Award and I hope the recognition of this award will contribute to my mission of making TPD research more accessible and bringing together TPD researchers from all over the globe, said Dr. Donovan.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Warner Bros., Olo, Centessa, and PayPal and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, October 27, 2022
U.S. Securities and Exchange Commission, NASDAQ, Churn, Polycystic kidney disease, CNTA, Lists of schools in England, AT, Securities Act of 1933, HBO Max, Registration statement, Class Action, Warner Bros., Liver, Observation, ADS, IPO, Patient, AT&T, Restaurant, News, DoorDash, Investment, Autosome, Farm, Â, A1AT, Partnership, Company, Form, Acquisition, AE, DNA, Growth, PayPal, Mergers and acquisitions, Section 11 of the Canadian Charter of Rights and Freedoms, Defendant, OLO, Prospectus, GLOBE, PYPL, NNA, HBO, SEC, Class, Contract, Register, Complaint, BID, AATD, Fraud, Warner, NYSE, Music, Audit, Food delivery, Risk management, Security (finance), Animal, Online shopping, P.C, Subway, Discovery, WarnerMedia

Discovery, Inc. (NASDAQ: WBD), Olo, Inc. (NYSE: OLO), Centessa Pharmaceuticals Plc (NASDAQ: CNTA), and PayPal Holdings, Inc. (NASDAQ: PYPL).

Key Points: 
  • Discovery, Inc. (NASDAQ: WBD), Olo, Inc. (NYSE: OLO), Centessa Pharmaceuticals Plc (NASDAQ: CNTA), and PayPal Holdings, Inc. (NASDAQ: PYPL).
  • For more information on the Warner Bros. class action go to: https://bespc.com/cases/WBD
    Olo provides software to restaurants to assist with online ordering and food-delivery coordination.
  • For more information on the PayPal class action go to: https://bespc.com/cases/PYPL
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Scip & Savor for a Cure Fundraiser Benefits the International Myeloma Foundation (IMF) and Family Reach

Retrieved on: 
Thursday, October 27, 2022
Storm, International Myeloma Foundation, Â, Music, Cancer, India Infoline, Leukemia, Family, SCIP, Patient, Foundation, Multiple myeloma, Storm Front, Scipione, Quality of life, Education, Scipio (cognomen), IMF, Motivation, Research, GLOBE, Black swan, Personality, Empathy, Support group, Nightclub, Restaurant, Pharmaceutical industry, Medical device

The Scip & Savor for a Cure Fundraiser was held on Saturday, October 15 at the Scipione residence in Medfield, MA.

Key Points: 
  • The Scip & Savor for a Cure Fundraiser was held on Saturday, October 15 at the Scipione residence in Medfield, MA.
  • I remember a story that Family Reach CEO Carla Tardif told me about family that they were helping.
  • The Scip & Savor for a Cure Fundraiser is still accepting donations to reach its goal.
  • Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest foundation focusing specifically on multiple myeloma.